These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25569461)

  • 1. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles.
    Chen J; Ormes JD; Higgins JD; Taylor LS
    Mol Pharm; 2015 Feb; 12(2):533-41. PubMed ID: 25569461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leaching of Lopinavir Amorphous Solid Dispersions in Acidic Media.
    Li N; Ormes JD; Taylor LS
    Pharm Res; 2016 Jul; 33(7):1723-35. PubMed ID: 27026009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of surfactants on the crystal growth of amorphous celecoxib.
    Mosquera-Giraldo LI; Trasi NS; Taylor LS
    Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
    Al-Obaidi H; Lawrence MJ; Buckton G
    J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
    Rahman M; Arevalo F; Coelho A; Bilgili E
    Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Surfactant and Surfactant-Polymer Interaction on Desupersaturation of Clotrimazole.
    Zhang W; Hate SS; Russell DJ; Hou HH; Nagapudi K
    J Pharm Sci; 2019 Oct; 108(10):3262-3271. PubMed ID: 31207217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Pharm Res; 2022 Feb; 39(2):381-397. PubMed ID: 35169959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
    Knopp MM; Nguyen JH; Becker C; Francke NM; Jørgensen EB; Holm P; Holm R; Mu H; Rades T; Langguth P
    Eur J Pharm Biopharm; 2016 Apr; 101():145-51. PubMed ID: 26899127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of surfactant selection and incorporation on in situ nanoparticle formation from amorphous solid dispersions.
    Yen CW; Kuhn R; Hu C; Zhang W; Chiang PC; Chen JZ; Hau J; Estevez A; Nagapudi K; Leung DH
    Int J Pharm; 2021 Sep; 607():120980. PubMed ID: 34371147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface composition of spray-dried particles of bovine serum albumin/trehalose/surfactant.
    Adler M; Unger M; Lee G
    Pharm Res; 2000 Jul; 17(7):863-70. PubMed ID: 10990207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of crystallization and growth of celecoxib nanoparticles formed from volatile microemulsions.
    Margulis-Goshen K; Weitman M; Major DT; Magdassi S
    J Pharm Sci; 2011 Oct; 100(10):4390-400. PubMed ID: 21630277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.
    Yang R; Zhang GGZ; Zemlyanov DY; Purohit HS; Taylor LS
    Pharm Res; 2023 Dec; 40(12):2817-2845. PubMed ID: 37052841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions.
    Deshpande TM; Shi H; Pietryka J; Hoag SW; Medek A
    Mol Pharm; 2018 Mar; 15(3):962-974. PubMed ID: 29345955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.